Cargando…

High-risk breast cancer patients: comparison of lymphocyte phenotypes and function in vitro

Detalles Bibliográficos
Autores principales:	Mohrmann, S, Oletzki, A, Karaoglu, A, Nitz, U, Koldovsky, U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300552/ http://dx.doi.org/10.1186/bcr369

Ejemplares similares

High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01
por: Nitz, U, et al.
Publicado: (2001)

Whole-body hyperthermia in the treatment of breast cancer
por: Rethfeldt, E, et al.
Publicado: (2001)

Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation
por: Wetzel, D, et al.
Publicado: (2001)

Spontaneous apoptosis of circulating T-lymphocytes and its correlation to their prolactin receptor expression and prolactin plasma levels in patients with breast cancer
por: Bauernhofer, T, et al.
Publicado: (2001)

Enhanced transendothelial in vitro migration of scleroderma lymphocytes
por: Stummvoll, GH, et al.
Publicado: (2001)

Phenotypes of lymphocytic alveolitis in our group of bronchoalveolar lavage fluids
por: Ondrejka, Gustav, et al.
Publicado: (2015)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Human hair follicle equivalents in vitro for transplantation and chip-based substance testing
por: Horland, R, et al.
Publicado: (2011)

New diagnostic test for high risk of breast cancer in Poland
por: Gorski, B
Publicado: (2011)

The effect of the combined administration of colloids and Ringer's Lactate on the coagulation system - an in vitro study using thrombelastography (roTEG(®))
por: Fries, D, et al.
Publicado: (2001)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Effects of granulocyte-colony stimulating factor (G-CSF) prophylaxis in high risk patients (ASA III and IV) with colorectal cancer on perioperative cytokine levels, complications and global quality of life
por: Torossian, A, et al.
Publicado: (2002)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

P01-008 – FMF genotype-phenotype correlations in Germany
por: Jeske, M, et al.
Publicado: (2013)

Comparison of four methods of presentation of breast specimens
por: Thompson, PA
Publicado: (2000)

Uncoated and coated blood contact surfaces of a hollow-fiber oxygenator: an in-vitro comparison
por: Baykut, D, et al.
Publicado: (1999)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
por: Guech-Ongey, Mercy, et al.
Publicado: (2010)

Primary prevention of breast cancer in high-risk women by monitoring epigenetic changes in nipple aspirates
por: van Diest, PJ, et al.
Publicado: (2009)

Increased risk due to ventricular arrhythmias after transmyocardial laser-revascularisation? Preliminary results
por: Brunner, M, et al.
Publicado: (1997)

Compartmentalized Ras signaling in lymphocytes
por: Philips, MR
Publicado: (2009)

Association of the Epstein-Barr virus with breast cancer: in vivo and in vitro studies
por: Bonnet-Duqeynoy, M, et al.
Publicado: (2001)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Does age influence surgical treatment for breast cancer?
por: Renne, M, et al.
Publicado: (2010)

Health-related quality of life of multiple organ dysfunction patients: changes and comparison with normative population data
por: Wehler, M, et al.
Publicado: (2002)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

How high risk are 'high-risk' surgical patients?
por: Gomersall, CD, et al.
Publicado: (2003)

Chemokines and Chemokine Receptors in Lymphocyte Traffic
por: Loetsacher, Pius
Publicado: (2000)

Calcium signals in lymphocyte activation and disease
por: Feske, S
Publicado: (2009)

Impact of norepinephrine, dopamine and substance P on the activation and function of CD8 lymphocytes
por: Strell, C, et al.
Publicado: (2009)

Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
por: Beesley, Jonathan, et al.
Publicado: (2012)

Folic acid and breast cancer risk
por: Durda, Katarzyna, et al.
Publicado: (2012)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

PW03-029 – Risk factors for AA-type amyloidosis in Germany
por: Blank, N, et al.
Publicado: (2013)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_vpeab2g56nel9qget1habhia8c